The seminal study by Boström et al. identified that 11 different inflammatory markers, including MMP-10, TWEAK, and HGF, have increased concentration in patients with MCI/AD compared to stable MCI preparing the ground for future use of inflammatory markers in prediction of progression risk to dementia [9]. This evidence concerns the gene HGF and Alzheimer disease.